Molecular insights on the peripheral and intra-tumoral effects of systemic high dose rIL-2 (Aldesleukin) administration for the treatment of metastatic melanoma

類似資料

• Update on use of aldesleukin for treatment of high-risk metastatic melanoma
  著者:: Amaria, Rodabe N, 等
  出版事項: (2015)
• A melanoma helper peptide vaccine increases Th1 cytokine production by leukocytes in peripheral blood and immunized lymph nodes
  著者:: Dillon, Patrick M, 等
  出版事項: (2014)
• Surgical Management of the Patient with Metastatic Melanoma to the Heart
  著者:: Judge, Joshua M., 等
  出版事項: (2013)
• Usefulness of prestudy assessment of patient willingness to undergo tissue biopsy for correlative studies in a melanoma vaccine trial
  著者:: Judge, Joshua M, 等
  出版事項: (2012)
• A Randomized Phase II Trial of Multi-epitope Vaccination with Melanoma Peptides for Cytotoxic T-Cells and Helper T-Cells for Patients with Metastatic Melanoma (E1602)
  著者:: Slingluff, Craig L., 等
  出版事項: (2013)